These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36382882)

  • 1. Phage-assisted, active site-directed ligand evolution of a potent and selective histone deacetylase 8 inhibitor.
    Morse JS; Sheng YJ; Hampton JT; Sylvain LD; Das S; Alugubelli YR; Chen PC; Yang KS; Xu S; Fierke CA; Liu WR
    Protein Sci; 2022 Dec; 31(12):e4512. PubMed ID: 36382882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amber obligate active site-directed ligand evolution technique for phage display.
    Tharp JM; Hampton JT; Reed CA; Ehnbom A; Chen PC; Morse JS; Kurra Y; Pérez LM; Xu S; Liu WR
    Nat Commun; 2020 Mar; 11(1):1392. PubMed ID: 32170178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Construction of a Genetically Encoded, Phage-Displayed Cyclic-Peptide Library.
    Chen PC; Liu WR
    Methods Mol Biol; 2021; 2355():219-230. PubMed ID: 34386961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Site Metal Identity Alters Histone Deacetylase 8 Substrate Selectivity: A Potential Novel Regulatory Mechanism.
    Castaneda CA; Lopez JE; Joseph CG; Scholle MD; Mrksich M; Fierke CA
    Biochemistry; 2017 Oct; 56(42):5663-5670. PubMed ID: 28937750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An amber-encoding helper phage for more efficient phage display of noncanonical amino acids.
    Hampton JT; Cho CD; Coleman DD; Geng ZZ; Chen PC; Dubey GK; Sylvain LD; Xu S; Liu WR
    Nucleic Acids Res; 2023 Jul; 51(13):6566-6577. PubMed ID: 37293959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetically selective and potent inhibitors of HDAC8.
    Schweipert M; Jänsch N; Sugiarto WO; Meyer-Almes FJ
    Biol Chem; 2019 May; 400(6):733-743. PubMed ID: 30521473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of binding of structurally similar ligands to histone deacetylase 8 sheds light on challenges in the rational design of potent and isozyme-selective inhibitors of the enzyme.
    Singh RK; Suzuki T; Mandal T; Balsubramanian N; Haldar M; Mueller DJ; Strode JA; Cook G; Mallik S; Srivastava DK
    Biochemistry; 2014 Dec; 53(48):7445-58. PubMed ID: 25407689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
    Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
    Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
    Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
    J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolved sequence contexts for highly efficient amber suppression with noncanonical amino acids.
    Pott M; Schmidt MJ; Summerer D
    ACS Chem Biol; 2014 Dec; 9(12):2815-22. PubMed ID: 25299570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.
    Decroos C; Clausen DJ; Haines BE; Wiest O; Williams RM; Christianson DW
    Biochemistry; 2015 Mar; 54(12):2126-35. PubMed ID: 25793284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel potential selective HDAC8 inhibitors by combine ligand-based, structure-based virtual screening and in-vitro biological evaluation.
    Debnath S; Debnath T; Bhaumik S; Majumdar S; Kalle AM; Aparna V
    Sci Rep; 2019 Nov; 9(1):17174. PubMed ID: 31748509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encoding Noncanonical Amino Acids into Phage Displayed Proteins.
    Díaz-Perlas C; Escobar-Rosales M; Morgan CW; Oller-Salvia B
    Methods Mol Biol; 2023; 2676():117-129. PubMed ID: 37277628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.
    Gantt SL; Gattis SG; Fierke CA
    Biochemistry; 2006 May; 45(19):6170-8. PubMed ID: 16681389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
    Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
    J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.
    Stoddard SV; May XA; Rivas F; Dodson K; Vijayan S; Adhika S; Parker K; Watkins DL
    Mol Inform; 2019 Mar; 38(3):e1800080. PubMed ID: 30369061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
    Kashyap K; Kakkar R
    J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine.
    Muth M; Jänsch N; Kopranovic A; Krämer A; Wössner N; Jung M; Kirschhöfer F; Brenner-Weiß G; Meyer-Almes FJ
    Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):577-585. PubMed ID: 30611847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
    Darwish S; Ghazy E; Heimburg T; Herp D; Zeyen P; Salem-Altintas R; Ridinger J; Robaa D; Schmidtkunz K; Erdmann F; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore-enabled virtual screening, molecular docking and molecular dynamics studies for identification of potent and selective histone deacetylase 8 inhibitors.
    Kashyap K; Kakkar R
    Comput Biol Med; 2020 Aug; 123():103850. PubMed ID: 32658783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.